Analgesics Market Trends 2023 | Segmentation, Outlook, Industry Report to 2033
According to FMI reports, the global analgesics market can soar at a rate CAGR
of 4.2% from 2023-2033. The net worth of the market share of the analgesics
industry is predicted to go from US$ 87.3 Mn in 2023 to over US$ 132.0 Mn by
2033.
People with acute, chronic diseases such as heart disease, cancer,
diabetes, stroke, and arthritis, as well as infectious diseases like
gastrointestinal, respiratory, and neurological ailments, are becoming
increasingly common. Painkiller demand is on the rise as these diseases become
more prevalent.
The geriatric population increase is a major factor in the increased
demand for analgesics, major pharmaceutical companies manufacture and
distribute analgesics, and consumer healthcare expenditure is rising.
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1306
Clinical trials will continue to be conducted to evaluate the safety and
efficacy of a wide range of therapeutic drugs, increasing the analgesics
market. Furthermore, analgesics market trends are primarily driven by the
growing number of elderly people, cardiovascular diseases, cancer, and
arthritis.
This is driven by technological advancements in the pharmaceutical
industry that allow advanced analgesic drugs to be manufactured, which will
create remunerative opportunities for the analgesics market forecast period.
Key Takeaways from the Analgesics Market Study
·
The global analgesics market expanded at 6%CAGR over
2017-2022.
·
The U.S. dominates the North American analgesics market with a total
share of 5%in 2022 and is projected to continue exhibiting high demand
registering a CAGR of 3.5%.
·
Surgical pain holds a revenue share of 3%in 2023 and is
projected to continue accounting for over half of sales in the market by 2033.
·
By drug type, the demand for opioids is projected to increase at a CAGR
of8%during the forecast period.
·
Based on distribution channels, hospital pharmacies led the analgesics
market with more than 1%market share with a CAGR of 5.4% in 2023.
·
The analgesics market is expected to increase at a notable CAGR of 4.2%.
Competitive Landscape for the Analgesics Market
In the development of non-opioid or non-addictive pain management
formulations, key players are focusing on novel and innovative approaches.
Manufacturers are expanding their markets, launching new products, and
receiving approvals to further strengthen their position in the market.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1306
Pfizer Inc., Sun Pharmaceutical Industries, Inc., Sanofi SA, AbbVie Inc.
(Allergan plc), Teva Pharmaceuticals, Boehringer Ingelheim International GmbH,
Janssen Pharmaceuticals, Inc. [Johnson & Johnson], Endo Pharmaceuticals
Inc., Purdue Pharmaceuticals L.P., Assertio Therapeutics, Inc., Mallinckrodt Pharmaceuticals,
Bayer AG, GlaxoSmithKline plc., Bausch Health Companies Inc., Novartis AG, and
others, the market is growing and establishing a strong global presence.
Analgesics Market Segmentation by Category
By Drug Class:
·
Opioids
·
NSAIDs
·
Local Anesthetics
·
Acetaminophen
By Indication:
·
Surgical Pain
·
Cancer Pain
·
Neuropathic Pain
By Route of Administration:
·
Oral
·
Parenteral
·
Transdermal
By Distribution Channel:
·
Hospital Pharmacies
·
Retail Pharmacies
·
Drug Store
·
Clinics
·
Others
Full
Report @
https://www.futuremarketinsights.com/reports/analgesics-market
Comments
Post a Comment